Source comparison
Wolverine Stack MK-677 Protocol Extended Recovery: Comparison
MK-677 (Ibutamoren) Ghrelin receptor agonist. Stimulates pulsatile GH and IGF-1 release from pituitary without suppressing endogenous production 12.5–25mg daily, evening preferred Systemic elevation of growth factors, enhanced protein synthesis, satellite cell
This comparison does not assign a generated winner or score.
- MK-677 (Ibutamoren)
- Ghrelin receptor agonist. Stimulates pulsatile GH and IGF-1 release from pituitary without suppressing endogenous production
- 12.5–25mg daily, evening preferred
- Systemic elevation of growth factors, enhanced protein synthesis, satellite cell activation
- Essential foundation. Provides permissive environment but insufficient alone for targeted tissue repair
- BPC-157
- Gastric-derived pentadecapeptide. Promotes angiogenesis, fibroblast activation, collagen synthesis at injury sites
- 250–500mcg twice daily, local subcutaneous injection
- Accelerated soft tissue healing (tendons, ligaments, muscle), reduced inflammation
- Most versatile repair peptide. Works synergistically with MK-677 to direct systemic growth factors to injury
- TB-500 (Thymosin Beta-4)
- Actin-binding peptide. Facilitates cell migration, modulates inflammation, supports extracellular matrix remodelling
- 2–5mg twice weekly (loading), 2mg weekly (maintenance)
- Enhanced flexibility, reduced scar tissue formation, systemic tissue repair
- Complements BPC-157 when injury involves multiple tissue types or chronic degeneration
- IGF-1 LR3 (optional)
- Synthetic IGF-1 analogue with extended half-life. Directly activates IGF-1 receptors without GH pathway
- 40–80mcg daily, post-workout
- Direct muscle hypertrophy and repair signalling
- Redundant if MK-677 is present. Adds complexity without proportional benefit in recovery contexts